Meetings
Upcoming meetings
PPRIG Proton Physics Workshop 7
Further information will be made available in due course.
Contacts:
If you require any further information, please contact pprig@npl.co.uk.
Previous meetings
PPRIG Proton Physics Workshop 6
9 ‑ 10 November 2023
The Proton Physics Research and Implementation Group (PPRIG) held the sixth PPRIG workshop at the National Physical Laboratory (NPL) on Thursday 9 and Friday 10 November 2023. The workshop was an opportunity to discuss the developments that have taken place over the past 4 years and to reenergise PPRIG and its future direction. The two-day event included invited speakers, debates, discussions, conference talks and poster sessions.
-
The speakers:
- Professor Harald Paganetti ‐ Director of Physics Research at Harvard Medical School
- Professor Anthony Lomax ‐ Chief Medical Physicist at the Paul Scherrer Institute
- Doctor Yolanda Prezado ‐ Team leader at Institut Curie and Research Director CNRS
PPRIG Proton Physics Workshop 5
7 — 8 February 2019
The Proton Physics Research and Implementation Group (PPRIG) held the fifth PPRIG workshop at the National Physical Laboratory (NPL) on Thursday 7 and Friday 8 February 2019.
Contacts:
If you require any further information, please contact Charles Fekete (T: 02089 436279) or Russell Thomas (M: 07738 893692).
PPRIG Proton Physics Workshop 4
7 – 8 December 2017
The fourth Proton Physics Research and Implementation Group (PPRIG) workshop was held at the National Physical Laboratory (NPL) on 7-8 December 2017.
NPL PPRIG Proton Therapy Physics Workshop 2016
1 – 2 December 2016
The third Proton Physics Research and Implementation Group (PPRIG) workshop was held at the National Physical Laboratory (NPL) on Thursday 1 and Friday 2 December 2016.
Find out more
UCLH Proton Therapy Symposium
22 – 23 October 2015
NPL PPRIG Proton Therapy Physics Workshop 2015
1 – 2 October 2015
NPL PPRIG Proton Therapy Physics Workshop 2014
12 – 13 March 2014
NPL organised and hosted a two-day PPRIG workshop on Proton Therapy Physics as part of the NPL Cancer Therapies Campaign.
Find out more